[1] Bray F, Ferlay J, Soerjomataram I, et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.   doi: 10.3322/caac.21492
[2] Alberti C.  Melatonin: the first hormone isolated from the pineal body[J]. Farmaco Sci, 1958, 13(8): 604-605.
[3]

Su SC, Hsieh MJ, Yang WE, et al. Cancer metastasis: Mechanisms of inhibition by melatonin[J/OL]. J Pineal Res, 2017, 62(1): e12370 [2019-01-17]. https://onlinelibrary.wiley.com/doi/full/10.1111/jpi.12370. DOI: 10.1111/jpi.12370.
[4] Singh M, Jadhav HR.  Melatonin: functions and ligands[J]. Drug Discov Today, 2014, 19(9): 1410-1418.   doi: 10.1016/j.drudis.2014.04.014
[5] Alonso-González C, González A, Martínez-Campa C, et al.  Melatonin enhancement of the radiosensitivity of human breast cancer cells is associated with the modulation of proteins involved in estrogen biosynthesis[J]. Cancer Lett, 2016, 370(1): 145-152.   doi: 10.1016/j.canlet.2015.10.015
[6]

Zhou QY, Gui SY, Zhou Q, et al. Melatonin Inhibits the Migration of Human Lung Adenocarcinoma A549 Cell Lines Involving JNK/MAPK Pathway[J/OL]. PLoS One, 2014, 9(7): e101132 [2019-01-17]. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0101132. DOI: 10.1371/journal.pone.0101132.
[7]

Lu YX, Chen DL, Wang DS, et al. Melatonin enhances sensitivity to fluorouracil in oesophageal squamous cell carcinoma through inhibition of Erk and Akt pathway[J/OL]. Cell Death Dis, 2016, 7(10): e2432 [2019-01-17]. https://www.nature.com/articles/cddis2016330. DOI: 10.1038/cddis.2016.330.
[8] Ju HQ, Li H, Tian T, et al.  Melatonin overcomes gemcitabine resistance in pancreatic ductal adenocarcinoma by abrogating nuclear factor-κB activation[J]. J Pineal Res, 2016, 60(1): 27-38.   doi: 10.1111/jpi.12285
[9]

Tai SY, Huang SP, Bao BY, et al. Urinary melatonin-sulfate/cortisol ratio and the presence of prostate cancer: A case-control study[J/OL]. Sci Rep, 2016, 6: 29606 [2019-01-17]. https://www.nature.com/articles/srep29606. DOI: 10.1038/srep29606.
[10]

Fic M, Gomulkiewicz A, Grzegrzolka J, et al. The Impact of Melatonin on Colon Cancer Cells' Resistance to Doxorubicin in An In Vitro Study[J/OL]. Int J Mol Sci, 2017, 18(7): 1396[2019-01-17]. https://www.mdpi.com/1422-0067/18/7/1396. DOI: 10.3390/ijms18071396.
[11] Bułdak RJ, Pilc-Gumuła K, Bułdak Ł, et al.  Effects of ghrelin, leptin and melatonin on the levels of reactive oxygen species, antioxidant enzyme activity and viability of the HCT 116 human colorectal carcinoma cell line[J]. Mol Med Rep, 2015, 12(2): 2275-2282.   doi: 10.3892/mmr.2015.3599
[12] Onseng K, Johns NP, Khuayjarernpanishk T, et al.  Beneficial Effects of Adjuvant Melatonin in Minimizing Oral Mucositis Complications in Head and Neck Cancer Patients Receiving Concurrent Chemoradiation[J]. J Altern Complement Med, 2017, 23(12): 957-963.   doi: 10.1089/acm.2017.0081
[13] Zou ZW, Liu T, Li Y, et al.  Melatonin suppresses thyroid cancer growth and overcomes radioresistance via inhibition of p65 phosphorylation and induction of ROS[J]. Redox Biol, 2018, 16: 226-236.   doi: 10.1016/j.redox.2018.02.025
[14] Hirota Y, Masunaga S, Kondo N, et al.  High linear-energy-transfer radiation can overcome radioresistance of glioma stem-like cells to low linear-energy-transfer radiation[J]. J Radiat Res, 2014, 55(1): 75-83.   doi: 10.1093/jrr/rrt095
[15] Pawlik TM, Keyomarsi K.  Role of cell cycle in mediating sensitivity to radiotherapy[J]. Int J Radiat Oncol Biol Phys, 2004, 59(4): 928-942.   doi: 10.1016/j.ijrobp.2004.03.005
[16] Li W, Fan M, Chen Y, et al.  Melatonin Induces Cell Apoptosis in AGS Cells Through the Activation of JNK and P38 MAPK and the Suppression of Nuclear Factor-Kappa B: A Novel Therapeutic Implication for Gastric Cancer[J]. Cell Physiol Biochem, 2015, 37(6): 2323-2338.   doi: 10.1159/000438587
[17] Wenzel U, Nickel A, Daniel H.  Melatonin potentiates flavone-induced apoptosis in human colon cancer cells by increasing the level of glycolytic end products[J]. Int J Cancer, 2005, 116(2): 236-242.   doi: 10.1002/ijc.20837
[18] Kontek R, Nowicka H.  The modulatory effect of melatonin on genotoxicity of irinotecan in healthy human lymphocytes and cancer cells[J]. Drug Chem Toxicol, 2013, 36(3): 335-342.   doi: 10.3109/01480545.2012.737805
[19] Alonso-González C, González A, Martínez-Campa C, et al.  Melatonin sensitizes human breast cancer cells to ionizing radiation by downregulating proteins involved in double-strand DNA break repair[J]. J Pineal Res, 2015, 58(2): 189-197.   doi: 10.1111/jpi.12205